Distributed Bio
develops a San Francisco-based cloud computational platform that provides antibody repertoire analysis and therapeutic discovery solutions... Read moreDistributed Bio
develops a San Francisco-based cloud computational platform that provides antibody repertoire analysis and therapeutic discovery solutions... Read more
News
Jan 11, 2021
Global Legal Chronicle
Distributed Bio: Charles River Laboratories International's $83 Million Acquisition Of Distributed Bio
Jan 05, 2021
BioPharma-Reporter
Distributed Bio: Deal sees Charles River Labs acquire large-molecule discovery platform
Jan 05, 2021
FierceBiotech
Distributed Bio: Charles River Laboratories spends $83M to snap up Distributed Bio to boost antibody work
Jun 03, 2020
Medical Buyer
Distributed Bio: Distributed Bio Partners With Mediar Therapeutics, Inc.
Mar 20, 2020
Techstartups
Distributed Bio: 'Pandemic' series scientist, Dr. Jacob Glanville, is developing antibody therapy drug to treat coronavirus (COVID-19) patients
Jan 14, 2020
MarketScreener
Distributed Bio: Distributed Bio : Collaborates With Washington University School of Medicine
Dec 12, 2019
Contract Pharma
Distributed Bio: Charles River Provides Access to Cosmic Antibody Library
Dec 09, 2019
BioSpace
Distributed Bio: Distributed Bio Launches Cosmic Antibody Library, Provides Charles River Clients Exclusive Access
Oct 10, 2019
BioPortfolio
Distributed Bio: Distributed Bio Announces Release of SuperHuman 3.0 Antibody Discovery Platform
Dec 12, 2018
4-traders
Distributed Bio: Distributed Bio : Inc and Good Therapeutics, Inc. Announce Multi-Target Collaboration
Distributed Bio Competitors
1
2
3
4
5
6
7
8
9
10